File Download

There are no files associated with this item.

Supplementary

Conference Paper: Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalization, severe complications, cardiovascular disease and mortality in patients with CKD: A case-control study

TitleVaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalization, severe complications, cardiovascular disease and mortality in patients with CKD: A case-control study
Authors
Cheng, Wing Tak Franco
Issue Date25-Jul-2023
Persistent Identifierhttp://hdl.handle.net/10722/357139

 

DC FieldValueLanguage
dc.contributor.authorCheng, Wing Tak Franco-
dc.date.accessioned2025-06-23T08:53:36Z-
dc.date.available2025-06-23T08:53:36Z-
dc.date.issued2023-07-25-
dc.identifier.urihttp://hdl.handle.net/10722/357139-
dc.languageeng-
dc.relation.ispartofAmerican College of Clinical Pharmacy Annual Meeting 2023 (11/11/2023-14/11/2023, Dallas)-
dc.titleVaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalization, severe complications, cardiovascular disease and mortality in patients with CKD: A case-control study -
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats